Open-Label, Long-Term Safety and Efficacy Study of Mim8 in Participants with Haemophilia A with or without Inhibitors

Disease Sites:

Not Available

Staging:

Phase III

Age Group:

Both

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Wheeler, Allison

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

02-15-2024

Trial Type:

Treatment

Protocol ID:

NCBH2401-FRONTIER4

National Clinical Trial ID:

NCT05685238

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available